PERCUTANEOUSLY IMPLANTABLE CATHETER-PORT SYSTEM - PRELIMINARY TECHNICAL RESULTS

The function and safety of a percutaneously implantable catheter-port system were studied in 44 patients with different diseases (32 patient s with malignant disease, 11 with peripheral arterial disease, and one with recurrent asthmatic attacks). Most patients required repeated lo cal-regional arterial infusion. Infection (two patients) and catheter- related complications (10 patients) were observed during the follow-up period (maximum length of follow-up, 542 days; mean, 177 days), Port migration or leakage did not occur. The data suggest that this new cat heter-port system is safe and easy to handle.